Treatment: relapsing phase of multiple sclerosis

被引：0

|

作者：

Kappos, L ^{[1
]}

Leppert, D

Radu, EV

机构：

[1] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland

[2] Univ Basel Hosp, Dept Neuroradiol, CH-4031 Basel, Switzerland

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 1998年 / 5卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：S23 / S24

页数：2

相关论文

共 50 条

[41] The pros and cons of early treatment of relapsing forms of multiple sclerosis
Xavier Montalban
Journal of Neurology, 2004, 251 : iv30 - iv34
[42] The cost of teriflunomide in the treatment of relapsing- remitting multiple sclerosis
Millar, J. Alasdair
NEW ZEALAND MEDICAL JOURNAL, 2019, 132 (1490) : 36 - 41
[43] Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders
Cohen, JA
Carter, JL
Kinkel, RP
Schwid, SR
JOURNAL OF NEUROIMMUNOLOGY, 1999, 98 (01) : 29 - 36
[44] Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis
Johnson, Kenneth P.
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (04) : 371 - 384
[45] An evaluation of dimethyl fumarate for the treatment of relapsing remitting multiple sclerosis
Valencia-Sanchez, Cristina
Carter, Jonathan L.
EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (12) : 1399 - 1405
[46] Olfactory threshold predicts treatment response in relapsing multiple sclerosis
Bsteh, G.
Hegen, H.
Berek, K.
Altmann, P.
Auer, M.
Di Pauli, F.
Leutmezer, F.
Rommer, P.
Wurth, S.
Zinganell, A.
Deisenhammer, F.
Berger, T.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 53 - 53
[47] Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis
Constantinescu, Simona E.
Constantinescu, Cris S.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (01) : 49 - 57
[48] Alemtuzumab may be a new, superior treatment for relapsing multiple sclerosis
Patience, Jonny
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (01) : 9 - 9
[49] Does natalizumab have a role in the treatment of relapsing multiple sclerosis?
Stangel, Martin
NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (09): : 476 - 477
[50] Interferon-β in the treatment of relapsing-remitting multiple sclerosis
Revel, M
PHARMACOLOGY & THERAPEUTICS, 2003, 100 (01) : 49 - 62

← 1 2 3 4 5 →